Chen Hong, Yin Juan, Wu Yixiang, Wang Yifan, Liu Yong, Dong Wei, Gao Beibei, Li Rongrong, Cheng Sumian, Wang Lifei
Department of Glaucoma, Hebei Eye Hospital, Hebei Key Laboratory of Ophthalmology, Hebei Provincial Clinical Research Center for Eye Diseases, 054001, Xingtai, Hebei, China.
Department of Ophthalmology Retina, Hebei Eye Hospital, Hebei Key Laboratory of Ophthalmology, Hebei Provincial Clinical Research Center for Eye Diseases, 054001, Xingtai, Hebei, China.
Heliyon. 2024 Jul 25;10(15):e34939. doi: 10.1016/j.heliyon.2024.e34939. eCollection 2024 Aug 15.
This study aims to investigate patient characteristics with lens zonular ligament abnormalities in Acute Primary Angle Closure (APAC), identifying related risk factors, and evaluating the efficacy of Pilocarpine, a miotic agent.
Retrospective case-control study.
Conducted as a retrospective case-control study at Hebei Provincial Eye Hospital from January 1, 2019, to December 31, 2021, the study included APAC cases undergoing ultrasound phacoemulsification with or without glaucoma surgery. Zonular ligament status was determined by intraoperative indicators such as lens equator visibility post-mydriasis and anterior capsule wrinkling during capsulorhexis. Patients were categorized into APAC and APAC with Lens Subluxation (APACLS) groups. Demographic details, Central Anterior Chamber Depth (ACD), Axial Length (AL), ACD difference between eyes (ACDD), Lens Thickness (LT), Lens Position (LP), and Relative Lens Position (RLP) were recorded and compared. Pilocarpine's impact on intraocular pressure reduction was assessed. Statistical analysis involved bilateral t-tests (for normally distributed data comparing both eyes in each group), non-parametric tests (for comparing two groups with non-normally distributed data), binary logistic regression, and Receiver Operating Characteristic (ROC) curve analysis for cutoff value determination related to zonular abnormalities.
The APAC and APACLS groups showed no significant difference in age of onset (70.11 ± 8.67 years vs. 70.11 ± 8.67 years, P = 0.159) or axial length of the eye (22.35 ± 0.64 mm vs. 22.36 ± 0.78 mm, P = 0.929). In the APACLS group, LT was greater (5.24 ± 0.37 mm vs. 5.01 ± 0.36 mm, P = 0.011), ACD was shallower (1.42 ± 0.24 mm vs. 1.69 ± 0.24 mm, P = 0.000), and ACDD was larger (0.38 ± 0.22 mm vs. 0.18 ± 0.18 mm, P = 0.000). The LP was lower (4.04 ± 0.32 vs. 4.20 ± 0.22, P = 0.013), and RLP was also lower (0.18 ± 0.02 vs. 0.19 ± 0.01, P = 0.015) in the APACLS group. A shallow ACD and a large ACDD were identified as risk factors associated with lens zonular abnormalities in the affected eyes (ACD OR value 63.97, P = 0.027; ACDD OR value 0.029, P = 0.027). Using ROC curve analysis, the cutoff value for ACDD was determined to be 0.375 mm, and for ACD, it was 1.6 mm. After pupil constriction with Pilocarpine eye drops, the proportion of patients whose intraocular pressure normalized was 75.36 % (52/69) in the APAC group and 71.43 % (25/35) in the APACLS group.
ACD and ACDD in the affected eye are indicative of increased risk for APACLS. An ACD <1.6 mm and ACDD >0.375 mm should prompt consideration of zonular ligament abnormalities. Pilocarpine as a miotic treatment is safe and effective for such patients.
本研究旨在调查急性原发性闭角型青光眼(APAC)患者晶状体悬韧带异常的特征,确定相关危险因素,并评估缩瞳剂毛果芸香碱的疗效。
回顾性病例对照研究。
本研究于2019年1月1日至2021年12月31日在河北省眼科医院进行,为回顾性病例对照研究,纳入了接受超声乳化白内障吸除术联合或不联合青光眼手术的APAC患者。通过术中指标确定悬韧带状态,如散瞳后晶状体赤道可见度和撕囊过程中前囊膜皱缩情况。患者分为APAC组和晶状体半脱位的APAC(APACLS)组。记录并比较人口统计学细节、中央前房深度(ACD)、眼轴长度(AL)、双眼ACD差值(ACDD)、晶状体厚度(LT)、晶状体位置(LP)和相对晶状体位置(RLP)。评估毛果芸香碱对降低眼压的影响。统计分析包括双侧t检验(用于比较每组双眼的正态分布数据)、非参数检验(用于比较两组非正态分布数据)、二元逻辑回归以及用于确定与悬韧带异常相关的截断值的受试者操作特征(ROC)曲线分析。
APAC组和APACLS组在发病年龄(70.11±8.67岁 vs. 70.11±8.67岁,P = 0.159)或眼轴长度(22.35±0.64mm vs. 22.36±0.78mm,P = 0.929)方面无显著差异。在APACLS组中,LT更大(5.24±0.37mm vs. 5.01±0.36mm,P = 0.011),ACD更浅(1.42±0.24mm vs. 1.69±0.24mm,P = 0.000),ACDD更大(0.38±0.22mm vs. 0.18±0.18mm,P = 0.000)。APACLS组的LP更低(4.04±0.32 vs. 4.20±0.22,P = 0.013),RLP也更低(0.18±0.02 vs. 0.19±0.01,P = 0.015)。浅ACD和大ACDD被确定为患眼晶状体悬韧带异常的相关危险因素(ACD的OR值为63.97,P = 0.027;ACDD的OR值为0.029,P = 0.027)。使用ROC曲线分析,确定ACDD的截断值为0.37 .5mm,ACD的截断值为1.6mm。用毛果芸香碱滴眼液缩瞳后,APAC组眼压恢复正常的患者比例为75.36%(52/69),APACLS组为71.43%(25/35)。
患眼的ACD和ACDD提示APACLS风险增加。ACD<1.6mm且ACDD>0.375mm应促使考虑悬韧带异常。毛果芸香碱作为缩瞳治疗对这类患者安全有效。